A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 Diabetes
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to compare the effect of a double dose of a study drug
known as insulin peglispro to a double dose of insulin glargine in participants who have type
2 diabetes. Participants will be treated with study insulin daily, in two 4-week study
periods. Each participant will receive insulin peglispro during one treatment period and
insulin glargine during the other treatment period.